Healthcare provider profile · identity verified

Tou Shoua John Lor, MD

Family Practice · KRONENWETTER, WI · NPI 1104184076

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	625	170
Omeprazole	Omeprazole	386	106
Amlodipine Besylate	Amlodipine Besylate	345	99
Losartan Potassium	Losartan Potassium	270	81
Levothyroxine Sodium	Levothyroxine Sodium	264	66
Lisinopril	Lisinopril	264	73
Metoprolol Succinate	Metoprolol Succinate	259	68
Gabapentin	Gabapentin	226	50
Rosuvastatin Calcium	Rosuvastatin Calcium	221	69
Metformin Hcl Er	Metformin Hcl	197	61
Ozempic	Semaglutide	188	32
Tamsulosin Hcl	Tamsulosin Hcl	181	53
Hydrochlorothiazide	Hydrochlorothiazide	163	51
Pravastatin Sodium	Pravastatin Sodium	152	45
Metformin Hcl	Metformin Hcl	140	39
Pantoprazole Sodium	Pantoprazole Sodium	134	38
Trazodone Hcl	Trazodone Hcl	126	31
Diclofenac Sodium	Diclofenac Sodium	125	52
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	121	29
Trulicity	Dulaglutide	117	17
Sertraline Hcl	Sertraline Hcl	113	32
Allopurinol	Allopurinol	99	29
Simvastatin	Simvastatin	97	29
Metoprolol Tartrate	Metoprolol Tartrate	94	25
Albuterol Sulfate Hfa	Albuterol Sulfate	93	35
Jardiance	Empagliflozin	76	19
Duloxetine Hcl	Duloxetine Hcl	75	21
Carvedilol	Carvedilol	74	23
Tramadol Hcl	Tramadol Hcl	71	18
Citalopram Hbr	Citalopram Hydrobromide	70	20
Potassium Chloride	Potassium Chloride	66	18
Tizanidine Hcl	Tizanidine Hcl	66	suppressed
Prednisone	Prednisone	60	44
Benazepril Hcl	Benazepril Hcl	56	16
Furosemide	Furosemide	55	20
Zolpidem Tartrate	Zolpidem Tartrate	55	15
Alprazolam	Alprazolam	53	21
Escitalopram Oxalate	Escitalopram Oxalate	53	15
Fluticasone Propionate	Fluticasone Propionate	53	23
Clopidogrel	Clopidogrel Bisulfate	52	15
Venlafaxine Hcl Er	Venlafaxine Hcl	52	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	48	11
Lorazepam	Lorazepam	46	14
Triamcinolone Acetonide	Triamcinolone Acetonide	46	26
Advair Hfa	Fluticasone Propion/Salmeterol	44	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	44	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	43	12
Warfarin Sodium	Warfarin Sodium	43	11
Ezetimibe	Ezetimibe	40	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	16
Eliquis	Apixaban	39	16
Meloxicam	Meloxicam	39	16
Lovastatin	Lovastatin	38	suppressed
Montelukast Sodium	Montelukast Sodium	38	suppressed
Alendronate Sodium	Alendronate Sodium	35	12
Spiriva Handihaler	Tiotropium Bromide	34	suppressed
Bumetanide	Bumetanide	33	suppressed
Donepezil Hcl	Donepezil Hcl	33	suppressed
Bupropion Hcl Sr	Bupropion Hcl	32	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	32	suppressed
Famotidine	Famotidine	31	12
Hydroxyzine Hcl	Hydroxyzine Hcl	31	suppressed
Finasteride	Finasteride	30	12
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	30	11
Bupropion Xl	Bupropion Hcl	29	suppressed
Ondansetron Odt	Ondansetron	29	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	28	suppressed
Symbicort	Budesonide/Formoterol Fumarate	28	suppressed
Celecoxib	Celecoxib	27	suppressed
Clonazepam	Clonazepam	27	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	27	suppressed
Spironolactone	Spironolactone	27	suppressed
Valsartan	Valsartan	26	suppressed
Atenolol	Atenolol	25	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	25	suppressed
Pregabalin	Pregabalin	25	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	24	suppressed
Clonidine Hcl	Clonidine Hcl	24	suppressed
Estradiol	Estradiol	24	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	24	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	24	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	22	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	20	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	20	suppressed
Trintellix	Vortioxetine Hydrobromide	20	suppressed
Lamotrigine	Lamotrigine	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Amoxicillin	Amoxicillin	18	13
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	18	suppressed
Irbesartan	Irbesartan	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Mounjaro	Tirzepatide	16	suppressed
Clotrimazole	Clotrimazole	15	suppressed
Tresiba Flextouch U-100	Insulin Degludec	15	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Repatha Sureclick	Evolocumab	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Linzess	Linaclotide	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Baclofen	Baclofen	12	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error